Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inequalities In Access to Treatment for Multiple Sclerosis In England Continue Despite Service Improvement Initiatives And Policy Reforms.
Optimal detection of infratentorial lesions with a combined dual-echo MRI sequence: "PT2".
Autoimmune thyroiditis associated with neuromyelitis optica (NMO).
Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Outcomes After Early Administration of Plasma Exchange in Pediatric Central Nervous System Inflammatory Demyelination.
Focal demyelinative damage and neighboring white matter integrity: an optic neuritis study.
Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Actively Induced Experimental Autoimmune Encephalomyelitis in Rats.
Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach.
Changes of Synaptic Plasticity in Multiple Sclerosis.
Presentation of multiple sclerosis with comorbid Huntington's disease.
Potential pathogens in multiple sclerosis (MS.
Therapeutic Cleavage of Anti-Aquaporin-4 Autoantibody in Neuromyelitis Optica by an Igg-Selective Proteinase.
Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.
Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System.
USPIO-Enhanced MRI Neuroimaging: A Review.
Unusual side effects of interferon Beta-1a in patient with multiple sclerosis.
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.
Exosomes as new diagnostic tools in CNS diseases.
Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - YES.
[Epidemiology of neuromyelitis optica].
Acute effects of varying intensities of treadmill walking exercise on inhibitory control in persons with multiple sclerosis: A pilot investigation.
IMaGe: Iterative Multilevel Probabilistic Graphical Model for Detection and Segmentation of Multiple Sclerosis Lesions in Brain MRI.
Microglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In Vivo.
Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood brain barrier.
Pages
« first
‹ previous
…
636
637
638
639
640
641
642
643
644
…
next ›
last »